Rayson, D <br/><br/>
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2012 
 - 1780-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Doxorubicin--administration & dosage<br/>Female<br/>Heart Diseases--chemically induced<br/>Humans<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Stroke Volume--drug effects<br/>Trastuzumab<br/>Ventricular Function, Left--drug effects<br/>Young Adult